LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,141,412 | -5.8% | 865,586 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $61,751,132 | +36.3% | 894,555 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $45,300,279 | -43.3% | 939,450 | -41.3% | 0.00% | +50.0% |
| Q4 2022 | $79,909,240 | +155.7% | 1,600,746 | +109.0% | 0.00% | 0.0% |
| Q3 2022 | $31,246,000 | -19.7% | 765,825 | +8.2% | 0.00% | 0.0% |
| Q2 2022 | $38,928,000 | +57.0% | 707,783 | +3.7% | 0.00% | +100.0% |
| Q1 2022 | $24,796,000 | -18.8% | 682,346 | +4.1% | 0.00% | 0.0% |
| Q4 2021 | $30,537,000 | +438.6% | 655,168 | +484.2% | 0.00% | – |
| Q3 2021 | $5,670,000 | +27.9% | 112,142 | +3.9% | 0.00% | – |
| Q2 2021 | $4,432,000 | +68.2% | 107,963 | +18.9% | 0.00% | – |
| Q1 2021 | $2,635,000 | +13.9% | 90,811 | +10.5% | 0.00% | – |
| Q4 2020 | $2,314,000 | – | 82,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |